National Health Service
Eli Lilly’s Mounjaro gets NICE approval for type 2 diabetes after cost-effectiveness review
Anika Sharma
Eli Lilly’s diabetes medication, Mounjaro (tirzepatide), has been on a winning streak since its US launch in May, and now ...
